Panic Disorder – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of panic disorder comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan). We report the prevalence of panic disorder for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, Europe, and Japan.
Clarivate Epidemiology’s panic disorder forecast will answer the following questions:
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of panic disorder over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
In total, Clarivate Epidemiology forecasts five panic disorder patient populations, as follows:
- Total panic disorder 12-month prevalent cases.
- Total panic disorder prevalent cases with mood disorder.
- Total panic disorder prevalent cases with anxiety disorder.
- Total panic disorder prevalent cases with impulse-control disorder.
- Total panic disorder prevalent with any mental disorder.
Note: Coverage may vary by country.
